US FDA Pressing Repackers To Disclose API Suppliers In Case Quality Issues Arise

 
• By Bowman Cox

The FDA's Francis Godwin tells Pink Sheet of progress battling supply chain obfuscation, which could allow marketing of adulterated drugs; Yino warning letter is latest salvo.  

Global-Company-Network
fda warnings are revealing suppliers • Source: Shutterstock

More from Manufacturing

More from Compliance